Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis
Trial details
- Registry ID
- NCT05671835
- Drugs studied
- TTI-101
TrialRedline tracks 1 clinical trial sponsored by Tvardi Therapeutics, Incorporated: 1 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Study of TTI-101 in Participants With Idiopathic Pulmonary FibrosisNCT05671835 | TTI-101 | Completed | 2025-08-14Actual |
Names as written in the registry records.